Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins
- PMID: 10711912
- DOI: 10.1001/archpsyc.57.3.261
Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins
Abstract
Background: In order to develop informed approaches to prevention and treatment of illicit psychoactive substance use, abuse, and dependence, we need to understand the sources of individual differences in risk.
Methods: In personal interviews with 1198 male-male twin pairs (708 monozygotic and 490 dizygotic) ascertained from a population-based registry, we assessed lifetime use, heavy use, and abuse of and dependence on cannabis, sedatives, stimulants, cocaine, opiates, and hallucinogens. Twin resemblance was assessed by probandwise concordance, odds ratio, tetrachoric correlations, and biometrical model fitting.
Results: Twin resemblance for substance use, heavy use, abuse, and dependence was substantial, and consistently greater in monozygotic than in dizygotic twins. For any drug use and for cannabis and hallucinogen use, model fitting suggested that twin resemblance was due to both genetic and familial-environmental factors. Twin resemblance for sedative, stimulant, cocaine, and opiate use, however, was caused solely by genetic factors. With 2 exceptions (cocaine abuse and stimulant dependence), twin resemblance for heavy use, abuse, and dependence resulted from only genetic factors, with heritability of liability usually ranging from 60% to 80%. No consistent evidence was found for violations of the equal environment assumption.
Conclusions: In accord with prior results in studies of women, the family environment plays a role in twin resemblance for some forms of substance use in men. However, twin resemblance for heavy use, abuse, and dependence in men is largely caused by genetic factors, and heritability estimates are high.
Similar articles
-
Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins.Acta Psychiatr Scand. 1999 May;99(5):368-76. doi: 10.1111/j.1600-0447.1999.tb07243.x. Acta Psychiatr Scand. 1999. PMID: 10353453
-
Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.Am J Psychiatry. 2003 Apr;160(4):687-95. doi: 10.1176/appi.ajp.160.4.687. Am J Psychiatry. 2003. PMID: 12668357
-
Cannabis use, abuse, and dependence in a population-based sample of female twins.Am J Psychiatry. 1998 Aug;155(8):1016-22. doi: 10.1176/ajp.155.8.1016. Am J Psychiatry. 1998. PMID: 9699687
-
Are there genetic influences on addiction: evidence from family, adoption and twin studies.Addiction. 2008 Jul;103(7):1069-81. doi: 10.1111/j.1360-0443.2008.02213.x. Epub 2008 May 20. Addiction. 2008. PMID: 18494843 Review.
-
Clinical characteristics of major depression that predict risk of depression in relatives.Arch Gen Psychiatry. 1999 Apr;56(4):322-7. doi: 10.1001/archpsyc.56.4.322. Arch Gen Psychiatry. 1999. PMID: 10197826 Review.
Cited by
-
Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins.Schizophr Bull. 2017 May 1;43(3):644-653. doi: 10.1093/schbul/sbw101. Schizophr Bull. 2017. PMID: 27431873 Free PMC article.
-
Specificity in genetic and environmental risk for prescription opioid misuse and heroin use.Psychol Med. 2023 Oct;53(14):6828-6837. doi: 10.1017/S003329172300034X. Epub 2023 Mar 22. Psychol Med. 2023. PMID: 36946318 Free PMC article.
-
Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes.Neuropsychopharmacology. 2010 Aug;35(9):1921-31. doi: 10.1038/npp.2010.64. Epub 2010 May 19. Neuropsychopharmacology. 2010. PMID: 20485328 Free PMC article.
-
The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.Ann Hum Genet. 2014 Jan;78(1):33-9. doi: 10.1111/ahg.12046. Epub 2013 Nov 25. Ann Hum Genet. 2014. PMID: 24359476 Free PMC article.
-
Opioids in pregnancy and neonatal abstinence syndrome.Semin Perinatol. 2015 Nov;39(7):561-5. doi: 10.1053/j.semperi.2015.08.013. Semin Perinatol. 2015. PMID: 26452318 Free PMC article. Review.